{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T07:11:02Z","timestamp":1791875462136,"version":"4.3.4"},"reference-count":247,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.pbb.2019.03.006","type":"journal-article","created":{"date-parts":[[2019,3,25]],"date-time":"2019-03-25T17:48:41Z","timestamp":1553536121000},"page":"60-73","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"special_numbering":"C","title":["Cannabinoids, interoception, and anxiety"],"prefix":"10.1016","volume":"180","author":[{"given":"Allyson K.","family":"Andrade","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Briana","family":"Renda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8992-7317","authenticated-orcid":false,"given":"Jennifer E.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2019.03.006_bb0005","doi-asserted-by":"crossref","first-page":"20564","DOI":"10.1073\/pnas.0706873104","article-title":"Retrograde endocannabinoid signaling at striatal synapses requires a regulated postsynaptic release step","volume":"104","author":"Adermark","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pbb.2019.03.006_bb0010","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1081\/ADA-120015873","article-title":"Rates of psychiatric comorbidity among U.S. residents with lifetime cannabis dependence","volume":"28","author":"Agosti","year":"2002","journal-title":"Am. J. Drug Alcohol Abuse"},{"key":"10.1016\/j.pbb.2019.03.006_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cne.903110102","article-title":"Organization of visceral and limbic connections in the insular cortex of the rat","volume":"311","author":"Allen","year":"1991","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.pbb.2019.03.006_bb0020","doi-asserted-by":"crossref","first-page":"e591","DOI":"10.1038\/tp.2015.84","article-title":"Increased anterior insula activity in anxious individuals is linked to diminished perceived control","volume":"5","author":"Alvarez","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pbb.2019.03.006_bb0025","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2174\/157015907780866884","article-title":"The cannabinoid CB2 receptor as a target for inflammation-dependent neurodegeneration","volume":"5","author":"Ashton","year":"2007","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.pbb.2019.03.006_bb0030","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.yfrne.2017.07.005","article-title":"Endocannabinoids: effectors of glucocorticoid signaling","volume":"47","author":"Balsevich","year":"2017","journal-title":"Front. Neuroendocrinol."},{"key":"10.1016\/j.pbb.2019.03.006_bb0035","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.neuropharm.2018.04.018","article-title":"Evaluation of reinforcing and aversive effects of voluntary \u0394 9 -tetrahydrocannabinol ingestion in rats","volume":"137","author":"Barrus","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2019.03.006_bb0040","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.biopsych.2012.06.003","article-title":"Resting-state functional and structural connectivity within an insula\u2013amygdala route specifically index state and trait anxiety","volume":"73","author":"Baur","year":"2013","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2019.03.006_bb0045","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.biopsych.2017.03.002","article-title":"Functional redundancy between canonical endocannabinoid signaling systems in the modulation of anxiety","volume":"82","author":"Bedse","year":"2017","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2019.03.006_bb0050","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/npp.2011.6","article-title":"Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-Na\u00efve social phobia patients","volume":"36","author":"Bergamaschi","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2019.03.006_bb0055","doi-asserted-by":"crossref","DOI":"10.1111\/add.13090","article-title":"Under pressure: adolescent substance users show exaggerated neural processing of aversive interoceptive stimuli","author":"Berk","year":"2015","journal-title":"Addiction"},{"key":"10.1016\/j.pbb.2019.03.006_bb0060","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/npp.2009.184","article-title":"Opposite effects of \u0394-9-tetrahydrocannabinol and cannabidiol on human brain function and psychopathology","volume":"35","author":"Bhattacharyya","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2019.03.006_bb0065","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.euroneuro.2014.11.018","article-title":"Impairment of inhibitory control processing related to acute psychotomimetic effects of cannabis","volume":"25","author":"Bhattacharyya","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pbb.2019.03.006_bb0070","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-14203-4","article-title":"Acute induction of anxiety in humans by delta-9-tetrahydrocannabinol related to amygdalar cannabinoid-1 (CB1) receptors","volume":"7","author":"Bhattacharyya","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pbb.2019.03.006_bb0075","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-14203-4","article-title":"Acute induction of anxiety in humans by delta-9-tetrahydrocannabinol related to amygdalar cannabinoid-1 (CB1) receptors","volume":"7","author":"Bhattacharyya","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.pbb.2019.03.006_bb0080","series-title":"N-acyl-dopamines: Novel Synthetic CB 1 Cannabinoid-receptor Ligands and Inhibitors of Anandamide Inactivation With Cannabimimetic Activity In Vitro and In Vivo","author":"Bisogno","year":"2000"},{"key":"10.1016\/j.pbb.2019.03.006_bb0085","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.euroneuro.2008.07.001","article-title":"Facilitation of contextual fear memory extinction and anti-anxiogenic effects of AM404 and cannabidiol in conditioned rats","volume":"18","author":"Bitencourt","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pbb.2019.03.006_bb0090","article-title":"The neuropsychopharmacology of cannabis: a review of human imaging studies","author":"Bloomfield","year":"2018","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.pbb.2019.03.006_bb0095","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14782","article-title":"Endocannabinoid signalling modulates susceptibility to traumatic stress exposure","volume":"8","author":"Bluett","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.pbb.2019.03.006_bb0100","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1002\/jts.20243","article-title":"Posttraumatic stress symptom severity predicts marijuana use coping motives among traumatic event-exposed marijuana users","volume":"20","author":"Bonn-Miller","year":"2007","journal-title":"J. Trauma. Stress."},{"key":"10.1016\/j.pbb.2019.03.006_bb0105","first-page":"966","article-title":"Neural basis of \u0394-9-tetrahydrocannabinol and cannabidiol: effects during response inhibition","volume":"64","author":"Borgwardt","year":"2008","journal-title":"BPS"},{"key":"10.1016\/j.pbb.2019.03.006_bb0110","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.bcp.2013.01.017","article-title":"Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease","volume":"85","author":"Borrelli","year":"2013","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.pbb.2019.03.006_bb0115","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1093\/carcin\/bgu205","article-title":"Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a cannabis-derived non-psychotropic cannabinoid","volume":"35","author":"Borrelli","year":"2014","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.pbb.2019.03.006_bb0120","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2147\/NSS.S152231","article-title":"Recent legalization of cannabis use: effects on sleep, health, and workplace safety","volume":"9","author":"Bowles","year":"2017","journal-title":"Nat. Sci. Sleep"},{"key":"10.1016\/j.pbb.2019.03.006_bb0125","first-page":"180","article-title":"Medicinal cannabis: history, pharmacology, and implications for the acute care setting","volume":"42","author":"Bridgeman","year":"2017","journal-title":"P T."},{"key":"10.1016\/j.pbb.2019.03.006_bb0130","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/sj.bjp.0707481","article-title":"Novel cannabinoid receptors","volume":"152","author":"Brown","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pbb.2019.03.006_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153327","article-title":"Behavioral characterization of the effects of cannabis smoke and anandamide in rats","volume":"11","author":"Bruijnzeel","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.pbb.2019.03.006_bb0140","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1016\/j.addbeh.2007.04.004","article-title":"Marijuana use motives and social anxiety among marijuana-using young adults","volume":"32","author":"Buckner","year":"2007","journal-title":"Addict. Behav."},{"key":"10.1016\/j.pbb.2019.03.006_bb0145","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.addbeh.2018.10.007","article-title":"Interrelationships among depression, anxiety, flourishing, and cannabis use in youth","volume":"89","author":"Butler","year":"2019","journal-title":"Addict. Behav."},{"key":"10.1016\/j.pbb.2019.03.006_bb0150","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00213-008-1168-x","article-title":"Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats","volume":"199","author":"Campos","year":"2008","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2019.03.006_bb0155","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.jpsychires.2012.08.012","article-title":"Cannabidiol blocks long-lasting behavioral consequences of predator threat stress: possible involvement of 5HT1A receptors","volume":"46","author":"Campos","year":"2012","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pbb.2019.03.006_bb0160","series-title":"Multiple Mechanisms Involved in the Large-spectrum Therapeutic Potential of Cannabidiol in Psychiatric Disorders","author":"Campos","year":"2012"},{"key":"10.1016\/j.pbb.2019.03.006_bb0165","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.adolescence.2018.03.013","article-title":"Effects of co-occurring marijuana use and anxiety on brain structure and functioning: a systematic review of adolescent studies","volume":"65","author":"Cancilliere","year":"2018","journal-title":"J. Adolesc."},{"key":"10.1016\/j.pbb.2019.03.006_bb0170","series-title":"Detection and Activity Profiling of Synthetic Cannabinoids and Their Metabolites With a Newly Developed Bioassay","author":"Cannaert","year":"2016"},{"key":"10.1016\/j.pbb.2019.03.006_bb0175","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1476-5381.2009.00515.x","article-title":"Evidence that the plant cannabinoid cannabigerol is a highly potent alpha2-adrenoceptor agonist and moderately potent 5HT1A receptor antagonist","volume":"159","author":"Cascio","year":"2010","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pbb.2019.03.006_bb0180","series-title":"Addict. Treat. Program","article-title":"Synthetic Cannabinoid Use: A Case Series of Adolescents","author":"Castellanos","year":"2011"},{"key":"10.1016\/j.pbb.2019.03.006_bb0185","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/s41386-018-0257-8","article-title":"Endocannabinoid control of the insular-bed nucleus of the stria terminalis circuit regulates negative affective behavior associated with alcohol abstinence","volume":"44","author":"Centanni","year":"2019","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2019.03.006_bb0190","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/BF00176846","article-title":"Discriminative stimulus and subjective effects of smoked marijuana in humans","volume":"94","author":"Chait","year":"1988","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2019.03.006_bb0195","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.drugalcdep.2017.03.030","article-title":"Dose-related effects of delta-9-THC on emotional responses to acute psychosocial stress","volume":"177","author":"Childs","year":"2017","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pbb.2019.03.006_bb0200","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1037\/pha0000221","article-title":"Previous cannabis exposure modulates the acute effects of delta-9-tetrahydrocannabinol on attentional salience and fear processing","volume":"26","author":"Colizzi","year":"2018","journal-title":"Exp. Clin. Psychopharmacol."},{"key":"10.1016\/j.pbb.2019.03.006_bb0205","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1093\/ibd\/izy014","article-title":"The use of cannabinoids in colitis: a systematic review and meta-analysis","volume":"24","author":"Couch","year":"2018","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.pbb.2019.03.006_bb0210","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.brainres.2014.11.034","article-title":"Cannabinoid modulation of drug reward and the implications of marijuana legalization","volume":"1628","author":"Covey","year":"2015","journal-title":"Brain Res."},{"key":"10.1016\/j.pbb.2019.03.006_bb0215","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.healthpol.2018.01.009","article-title":"The Canadian Cannabis Act legalizes and regulates recreational cannabis use in 2018","volume":"122","author":"Cox","year":"2018","journal-title":"Health Policy"},{"key":"10.1016\/j.pbb.2019.03.006_bb0220","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nrn894","article-title":"How do you feel? Interoception: the sense of the physiological condition of the body","volume":"3","author":"Craig","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.pbb.2019.03.006_bb0225","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0959-4388(03)00090-4","article-title":"Interoception: the sense of the physiological condition of the body","volume":"13","author":"Craig","year":"2003","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.pbb.2019.03.006_bb0230","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nrn2555","article-title":"How do you feel\u2014now? The anterior insula and human awareness","volume":"10","author":"Craig","year":"2009","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.pbb.2019.03.006_bb0235","doi-asserted-by":"crossref","first-page":"9371","DOI":"10.1073\/pnas.161191698","article-title":"Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase","volume":"98","author":"Cravatt","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pbb.2019.03.006_bb0240","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugpo.2016.04.013","article-title":"The Cannabis Policy Framework by the Centre for Addiction and Mental Health: a proposal for a public health approach to cannabis policy in Canada","volume":"34","author":"Cr\u00e9pault","year":"2016","journal-title":"Int. J. Drug Policy"},{"key":"10.1016\/j.pbb.2019.03.006_bb0245","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/sj.npp.1300340","article-title":"Effects of cannabidiol (CBD) on regional cerebral blood flow","volume":"29","author":"Crippa","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2019.03.006_bb0250","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/hup.1048","article-title":"Cannabis and anxiety: a critical review of the evidence","volume":"24","author":"Crippa","year":"2009","journal-title":"Hum. Psychopharmacol. Clin. Exp."},{"key":"10.1016\/j.pbb.2019.03.006_bb0255","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/nn1176","article-title":"Neural systems supporting interoceptive awareness","volume":"7","author":"Critchley","year":"2004","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.pbb.2019.03.006_bb0260","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/bs.apha.2017.05.001","article-title":"Spicing up pharmacology: a review of synthetic cannabinoids from structure to adverse events","volume":"80","author":"Davidson","year":"2017","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.pbb.2019.03.006_bb0265","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.biopsych.2015.12.021","article-title":"Interactions between anandamide and corticotropin-releasing factor signaling modulate human amygdala function and risk for anxiety disorders: an imaging genetics strategy for modeling molecular interactions","volume":"80","author":"Demers","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2019.03.006_bb0270","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.lfs.2005.05.055","article-title":"Cannabinoid signalling","volume":"78","author":"Demuth","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.pbb.2019.03.006_bb0275","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1089\/brain.2011.0030","article-title":"Anxiety modulates insula recruitment in resting-state functional magnetic resonance imaging in youth and adults","volume":"1","author":"Dennis","year":"2011","journal-title":"Brain Connect."},{"key":"10.1016\/j.pbb.2019.03.006_bb0280","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0026-895X(25)09876-1","article-title":"Determination and characterization of a cannabinoid receptor in rat brain","volume":"34","author":"Devane","year":"1988","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.pbb.2019.03.006_bb0285","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.pbb.2019.03.006_bb0290","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1111\/epi.12631","article-title":"Cannabidiol: pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders","volume":"55","author":"Devinsky","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.pbb.2019.03.006_bb0295","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1038\/nrd.2018.115","article-title":"New approaches and challenges to targeting the endocannabinoid system","volume":"17","author":"Di Marzo","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.pbb.2019.03.006_bb0300","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nn1457","article-title":"Endocannabinoid control of food intake and energy balance","volume":"8","author":"Di Marzo","year":"2005","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.pbb.2019.03.006_bb0305","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1007\/s13311-015-0374-6","article-title":"The endocannabinoid system and its modulation by phytocannabinoids","volume":"12","author":"Di Marzo","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.pbb.2019.03.006_bb0310","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1038\/sj.npp.1300496","article-title":"The psychotomimetic effects of Intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis","volume":"29","author":"D'Souza","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2019.03.006_bb0315","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.addbeh.2017.11.005","article-title":"The association between adolescent cannabis use and anxiety: a parallel process analysis","volume":"78","author":"Duperrouzel","year":"2018","journal-title":"Addict. Behav."},{"key":"10.1016\/j.pbb.2019.03.006_bb0320","first-page":"115","article-title":"Neural circuits in anxiety and stress disorders: a focused review","volume":"11","author":"Duval","year":"2015","journal-title":"Ther. Clin. Risk Manag."},{"key":"10.1016\/j.pbb.2019.03.006_bb0325","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00213-011-2566-z","article-title":"Anxiogenic-like effects of chronic cannabidiol administration in rats","volume":"221","author":"ElBatsh","year":"2012","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2019.03.006_bb0330","series-title":"Archival Report Changes in Cannabis Potency Over the Last 2 Decades (1995\u20132014): Analysis of Current Data in the United States","author":"Elsohly","year":"2016"},{"key":"10.1016\/j.pbb.2019.03.006_bb0335","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/0269881112460109","article-title":"Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment","volume":"27","author":"Englund","year":"2013","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pbb.2019.03.006_bb0340","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1177\/0269881115615104","article-title":"The effect of five day dosing with THCV on THC-induced cognitive, psychological and physiological effects in healthy male human volunteers: a placebo-controlled, double-blind, crossover pilot trial","volume":"30","author":"Englund","year":"2016","journal-title":"J. Psychopharmacol."},{"issue":"8","key":"10.1016\/j.pbb.2019.03.006_bb0345","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S2215-0366(17)30075-5","article-title":"Can We Make Cannabis Safer?","volume":"4","author":"Englund","year":"2017","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.pbb.2019.03.006_bb0350","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.drugalcdep.2011.01.012","article-title":"Synthetic cannabinoid JWH-018 and psychosis: an explorative study","volume":"117","author":"Every-Palmer","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pbb.2019.03.006_bb0355","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/da.22735","article-title":"Clinical and functional outcomes of cannabis use among individuals with anxiety disorders: a 3-year population-based longitudinal study","volume":"35","author":"Feingold","year":"2018","journal-title":"Depress. Anxiety"},{"key":"10.1016\/j.pbb.2019.03.006_bb0360","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0166-2236(99)01491-5","article-title":"The endogenous cannabinoid system and brain development","volume":"23","author":"Fern\u00e1ndez-Ruiz","year":"2000","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pbb.2019.03.006_bb0365","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1111\/ejn.13951","article-title":"Delta-9-tetrahydrocannabinol potentiates fear memory salience through functional modulation of mesolimbic dopaminergic activity states","volume":"47","author":"Fitoussi","year":"2018","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pbb.2019.03.006_bb0370","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1177\/0269881109104904","article-title":"Effects of \u03949-tetrahydrocannabinol on reward and anxiety in rats exposed to chronic unpredictable stress","volume":"24","author":"Fokos","year":"2010","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pbb.2019.03.006_bb0375","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1093\/schbul\/sbu098","article-title":"How cannabis causes paranoia: using the intravenous administration of \u22069-tetrahydrocannabinol (THC) to identify key cognitive mechanisms leading to paranoia","volume":"41","author":"Freeman","year":"2015","journal-title":"Schizophr. Bull."},{"key":"10.1016\/j.pbb.2019.03.006_bb0380","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1001\/archgenpsychiatry.2008.519","article-title":"Distinct effects of \u03949-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing","volume":"66","author":"Fusar-Poli","year":"2009","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.pbb.2019.03.006_bb0385","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.molmed.2003.09.005","article-title":"Anandamide hydrolysis: a new target for anti-anxiety drugs?","volume":"9","author":"Gaetani","year":"2003","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.pbb.2019.03.006_bb0390","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1432-1033.1995.tb20780.x","article-title":"Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations","volume":"232","author":"Galiegue","year":"1995","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.pbb.2019.03.006_bb0395","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/0269881110379507","article-title":"Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice","volume":"25","author":"Garc\u00eda-Guti\u00e9rrez","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pbb.2019.03.006_bb0400","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.pbb.2003.12.019","article-title":"Unconditioned and conditioned anxiogenic effects of the cannabinoid receptor agonist CP 55,940 in the social interaction test","volume":"77","author":"Genn","year":"2004","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2019.03.006_bb0405","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0306-4522(96)00428-9","article-title":"Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain","volume":"77","author":"Glass","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2019.03.006_bb0410","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s00213-010-2036-z","article-title":"The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors","volume":"213","author":"Gomes","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2019.03.006_bb0415","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0091-6773(72)80191-3","article-title":"Effects of Cannabis sativa extract on conditioned fear","volume":"7","author":"Gonz\u00e1lez","year":"1972","journal-title":"Behav. Biol."},{"key":"10.1016\/j.pbb.2019.03.006_bb0420","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0091-6773(72)80191-3","article-title":"Effects of cannabis sativa extract on conditioned fear","volume":"7","author":"Gonz\u00e1lez","year":"1972","journal-title":"Behav. Biol."},{"key":"10.1016\/j.pbb.2019.03.006_bb0425","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1001\/jamapsychiatry.2014.2206","article-title":"Identification of a common neurobiological substrate for mental illness","volume":"72","author":"Goodkind","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.pbb.2019.03.006_bb0430","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1007\/s11481-012-9399-3","article-title":"A cannabigerol quinone alleviates neuroinflammation in a chronic model of multiple sclerosis","volume":"7","author":"Granja","year":"2012","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.pbb.2019.03.006_bb0435","doi-asserted-by":"crossref","first-page":"3879","DOI":"10.1523\/JNEUROSCI.2737-14.2015","article-title":"Corticotropin-releasing hormone drives anandamide hydrolysis in the amygdala to promote anxiety","volume":"35","author":"Gray","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2019.03.006_bb0440","first-page":"495","article-title":"The therapeutic potential of cannabis and cannabinoids","volume":"109","author":"Grotenhermen","year":"2012","journal-title":"Dtsch. Arztebl. Int."},{"key":"10.1016\/j.pbb.2019.03.006_bb0445","doi-asserted-by":"crossref","first-page":"pyv091","DOI":"10.1093\/ijnp\/pyv091","article-title":"Impaired 2-AG signaling in hippocampal glutamatergic neurons: aggravation of anxiety-like behavior and unaltered seizure susceptibility","volume":"19","author":"Guggenhuber","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pbb.2019.03.006_bb0450","first-page":"1","article-title":"Legalizing cannabis violates the UN drug control treaties, but progressive countries like Canada have options","volume":"49","author":"Habibi","year":"2018","journal-title":"Ottawa Law Rev."},{"key":"10.1016\/j.pbb.2019.03.006_bb0455","doi-asserted-by":"crossref","first-page":"453","DOI":"10.15171\/ijhpm.2016.63","article-title":"Legalizing and regulating marijuana in Canada: review of potential economic, social, and health impacts","volume":"5","author":"Hajizadeh","year":"2016","journal-title":"Int. J. Health Policy Manag."},{"key":"10.1016\/j.pbb.2019.03.006_bb0460","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1111\/j.1460-9568.2004.03293.x","article-title":"Context-dependent effects of CB1 cannabinoid gene disruption on anxiety-like and social behaviour in mice","volume":"19","author":"Haller","year":"2004","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pbb.2019.03.006_bb0465","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1146\/annurev-neuro-071714-034111","article-title":"Long-range neural synchrony in behavior","volume":"38","author":"Harris","year":"2015","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.pbb.2019.03.006_bb0470","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.bbr.2012.02.048","article-title":"Withdrawal from THC during adolescence: sex differences in locomotor activity and anxiety","volume":"231","author":"Harte-Hargrove","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2019.03.006_bb0475","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.neuropharm.2007.06.002","article-title":"Pharmacological evidence for the involvement of diacylglycerol lipase in depolarization-induced endocannabinoid release","volume":"54","author":"Hashimotodani","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2019.03.006_bb0480","series-title":"Correlating Anterior Insula Gray Matter Volume Changes in Young People With Clinical and Neurocognitive Outcomes: An MRI Study","author":"Hatton","year":"2012"},{"key":"10.1016\/j.pbb.2019.03.006_bb0485","series-title":"Characterization and Localization of Cannabinoid Receptors in Rat Brain: A Quantitative In Vitro Autoradiographic Study","author":"Herkenham","year":"1991"},{"key":"10.1016\/j.pbb.2019.03.006_bb0490","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.neuroscience.2011.12.030","article-title":"Endocannabinoid signaling, glucocorticoid-mediated negative feedback, and regulation of the hypothalamic-pituitary-adrenal axis","volume":"204","author":"Hill","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2019.03.006_bb0495","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/npp.2017.162","article-title":"Integrating endocannabinoid signaling and cannabinoids into the biology and treatment of posttraumatic stress disorder","volume":"43","author":"Hill","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2019.03.006_bb0500","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1172\/JCI19376","article-title":"Endocannabinoids and the regulation of body fat: the smoke is clearing","volume":"112","author":"Horvath","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.pbb.2019.03.006_bb0505","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/bs.apha.2017.03.007","article-title":"CB1 and CB2 receptor pharmacology","volume":"80","author":"Howlett","year":"2017","journal-title":"Adv. Pharmacol."},{"key":"10.1016\/j.pbb.2019.03.006_bb0510","doi-asserted-by":"crossref","DOI":"10.1016\/S0026-895X(25)15066-9","article-title":"Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes","volume":"26","author":"Howlett","year":"1984","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.pbb.2019.03.006_bb0515","series-title":"Marijuana: A Short History","author":"Hudak","year":"2016"},{"key":"10.1016\/j.pbb.2019.03.006_bb0520","doi-asserted-by":"crossref","first-page":"4723","DOI":"10.1007\/s00213-014-3630-2","article-title":"Acute subjective effects after smoking joints containing up to 69 mg \u03949-tetrahydrocannabinol in recreational users: a randomized, crossover clinical trial","volume":"231","author":"Hunault","year":"2014","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2019.03.006_bb0525","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/jnc.13267","article-title":"Genetic deletion of monoacylglycerol lipase leads to impaired cannabinoid receptor CB\u2081R signaling and anxiety-like behavior","volume":"135","author":"Imperatore","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pbb.2019.03.006_bb0530","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/sj.tpj.6500431","article-title":"Involvement of cannabinoid CB2 receptor in alcohol preference in mice and alcoholism in humans","volume":"7","author":"Ishiguro","year":"2007","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.pbb.2019.03.006_bb0535","series-title":"Brain Cannabinoid CB2 Receptor in Schizophrenia","author":"Ishiguro","year":"2010"},{"key":"10.1016\/j.pbb.2019.03.006_bb0540","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.3390\/molecules23081836","article-title":"Cannabinoid CB2 receptor gene and environmental interaction in the development of psychiatric disorders","volume":"23","author":"Ishiguro","year":"2018","journal-title":"Molecules"},{"key":"10.1016\/j.pbb.2019.03.006_bb0545","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/mind\/os-IX.34.188","article-title":"II\u2014What is an emotion?","volume":"9","author":"James","year":"1884","journal-title":"Mind"},{"key":"10.1016\/j.pbb.2019.03.006_bb0550","doi-asserted-by":"crossref","first-page":"14136","DOI":"10.1073\/pnas.96.24.14136","article-title":"Cannabinoid-induced mesenteric vasodilation through an endothelial site distinct from CB1 or CB2 receptors","volume":"96","author":"J\u00e1rai","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.pbb.2019.03.006_bb0555","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3389\/fnins.2018.00730","article-title":"Cannabis and the anxiety of fragmentation\u2014a systems approach for finding an anxiolytic cannabis chemotype","volume":"12","author":"Kamal","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.pbb.2019.03.006_bb0560","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.pbb.2017.10.012","article-title":"Acute and long-term effects of \u03949-tetrahydrocannabinol on object recognition and anxiety-like activity are age- and strain-dependent in mice","volume":"163","author":"Kasten","year":"2017","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2019.03.006_bb0565","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s10519-018-9894-2","article-title":"Short-term genetic selection for adolescent locomotor sensitivity to delta9-tetrahydrocannabinol (THC)","volume":"48","author":"Kasten","year":"2018","journal-title":"Behav. Genet."},{"key":"10.1016\/j.pbb.2019.03.006_bb0570","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/nm803","article-title":"Modulation of anxiety through blockade of anandamide hydrolysis","volume":"9","author":"Kathuria","year":"2003","journal-title":"Nat. Med."},{"key":"10.1016\/j.pbb.2019.03.006_bb0575","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1523\/JNEUROSCI.19-11-04544.1999","article-title":"Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons","volume":"19","author":"Katona","year":"1999","journal-title":"J. Neurosci."},{"issue":"136","key":"10.1016\/j.pbb.2019.03.006_bb0580","article-title":"A positive association between anxiety disorders and cannabis use or cannabis use disorders in the general population--a meta-analysis of 31 studies","volume":"14","author":"Kedzior","year":"2014","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.pbb.2019.03.006_bb0585","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.bbr.2015.01.001","article-title":"Part II: strain- and sex-specific effects of adolescent exposure to THC on adult brain and behaviour: variants of learning, anxiety and volumetric estimates","volume":"288","author":"Keeley","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2019.03.006_bb0590","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.phrs.2007.09.006","article-title":"The endocannabinoid system in the processing of anxiety and fear and how CB1 receptors may modulate fear extinction","volume":"56","author":"Lafen\u00eatre","year":"2007","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.pbb.2019.03.006_bb0595","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.neuropharm.2009.07.014","article-title":"Bidirectional regulation of novelty-induced behavioral inhibition by the endocannabinoid system","volume":"57","author":"Lafen\u00eatre","year":"2009","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2019.03.006_bb0600","doi-asserted-by":"crossref","first-page":"285","DOI":"10.15171\/ijhpm.2016.124","article-title":"The challenges of projecting the public health impacts of marijuana legalization in Canada comment on \u201cLegalizing and regulating marijuana in Canada: review of potential economic, social, and health impacts\u201d","volume":"6","author":"Lake","year":"2016","journal-title":"Int. J. Health Policy Manag."},{"key":"10.1016\/j.pbb.2019.03.006_bb0605","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.tics.2011.05.009","article-title":"Empirical support for higher-order theories of conscious awareness","volume":"15","author":"Lau","year":"2011","journal-title":"Trends Cogn. Sci."},{"key":"10.1016\/j.pbb.2019.03.006_bb0610","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1007\/s00018-006-6027-5","article-title":"The roles of cannabinoid and dopamine receptor systems in neural emotional learning circuits: implications for schizophrenia and addiction","volume":"63","author":"Laviolette","year":"2006","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.pbb.2019.03.006_bb0615","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/mp.2016.1","article-title":"Overshadowed by the amygdala: the bed nucleus of the stria terminalis emerges as key to psychiatric disorders","volume":"21","author":"Lebow","year":"2016","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.pbb.2019.03.006_bb0620","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1146\/annurev.neuro.23.1.155","article-title":"Emotion circuits in the brain","volume":"23","author":"LeDoux","year":"2000","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.pbb.2019.03.006_bb0625","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1176\/appi.ajp.2016.16030353","article-title":"Using neuroscience to help understand fear and anxiety: a two-system framework","volume":"173","author":"LeDoux","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pbb.2019.03.006_bb0630","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1515\/jbcpp-2015-0080","article-title":"GPR55-a putative \u201ctype 3\u201d cannabinoid receptor in inflammation","volume":"27","author":"Lehmann","year":"2016","journal-title":"J. Basic Clin. Physiol. Pharmacol."},{"key":"10.1016\/j.pbb.2019.03.006_bb0635","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbr.2009.09.045","article-title":"Involvement of the prelimbic prefrontal cortex on cannabidiol-induced attenuation of contextual conditioned fear in rats","volume":"207","author":"Lemos","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2019.03.006_bb0640","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1038\/s41386-018-0064-2","article-title":"Repeated social defeat-induced neuroinflammation, anxiety-like behavior and resistance to fear extinction were attenuated by the cannabinoid receptor agonist WIN55,212-2","volume":"43","author":"Lisboa","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2019.03.006_bb0645","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.pbb.2018.05.003","article-title":"Reduced type III neuregulin 1 expression does not modulate the behavioural sensitivity of mice to acute \u03949-tetrahydrocannabinol (D9-THC)","volume":"170","author":"Lloyd","year":"2018","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2019.03.006_bb0650","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.biopsych.2015.07.028","article-title":"An introduction to the endogenous cannabinoid system","volume":"79","author":"Lu","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2019.03.006_bb0655","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/nrn4036","article-title":"The endocannabinoid system in guarding against fear, anxiety and stress","volume":"16","author":"Lutz","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.pbb.2019.03.006_bb0660","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroscience.2018.10.032","article-title":"Wnt7a in mouse insular cortex contributes to anxiety-like behavior during protracted abstinence from morphine","author":"Ma","year":"2018","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2019.03.006_bb0665","series-title":"Cannabinoid Receptors and Endocannabinoids: Evidence for New Players","author":"Mackie","year":"2006"},{"key":"10.1016\/j.pbb.2019.03.006_bb0670","series-title":"Santo Daime and Santa Maria\u2014The Licit Ritual Use of Ayabuasca and the Illicit Use of Cannabis in a Brazilian Amazonian Religion","author":"Macrae","year":"1998"},{"key":"10.1016\/j.pbb.2019.03.006_bb0675","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.17r11839","article-title":"Association of cannabis with long-term clinical symptoms in anxiety and mood disorders","volume":"79","author":"Mammen","year":"2018","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.pbb.2019.03.006_bb0680","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.bcp.2018.09.013","article-title":"Role of the endocannabinoid system in drug addiction","volume":"157","author":"Manzanares","year":"2018","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.pbb.2019.03.006_bb0685","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.2174\/138955709789957468","article-title":"The critical role of the endocannabinoid system in emotional homeostasis: avoiding excess and deficiencies","volume":"9","author":"Marco","year":"2009","journal-title":"Mini-Rev. Med. Chem."},{"key":"10.1016\/j.pbb.2019.03.006_bb0690","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00008877-200402000-00003","article-title":"Involvement of 5-HT1A receptors in behavioural effects of the cannabinoid receptor agonist CP 55,940 in male rats","volume":"15","author":"Marco","year":"2004","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.pbb.2019.03.006_bb0695","doi-asserted-by":"crossref","first-page":"4966","DOI":"10.2174\/138161212802884780","article-title":"Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers","volume":"18","author":"Martin-Santos","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.pbb.2019.03.006_bb0700","doi-asserted-by":"crossref","first-page":"4966","DOI":"10.2174\/138161212802884780","article-title":"Acute effects of a single, oral dose of d9-tetrahydrocannabinol (THC) and cannabidiol (CBD) administration in healthy volunteers","volume":"18","author":"Martin-Santos","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.pbb.2019.03.006_bb0705","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.pbb.2014.04.014","article-title":"Blunting of the HPA-axis underlies the lack of preventive efficacy of early post-stressor single-dose Delta-9-tetrahydrocannabinol (THC)","volume":"122","author":"Mayer","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2019.03.006_bb0710","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1124\/mol.107.041863","article-title":"Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: evidence for a site distinct from CB1 and CB2","volume":"73","author":"McHugh","year":"2008","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.pbb.2019.03.006_bb0715","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF00430486","article-title":"Suppression of the cardiac conditioned response by delta-9-tetrahydrocannabinol: a comparison with other drugs","volume":"50","author":"McLendon","year":"1976","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2019.03.006_bb0720","series-title":"Laser-induced Damage in Optical Materials","first-page":"215","article-title":"U. Kingdom","volume":"vol. 3902","author":"Mclnnes","year":"2000"},{"key":"10.1016\/j.pbb.2019.03.006_bb0725","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1146\/annurev-psych-113011-143739","article-title":"The endocannabinoid system and the brain","volume":"64","author":"Mechoulam","year":"2013","journal-title":"Annu. Rev. Psychol."},{"key":"10.1016\/j.pbb.2019.03.006_bb0730","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1126\/science.169.3945.611","article-title":"Chemical basis of hashish activity","volume":"169","author":"Mechoulam","year":"1970","journal-title":"Science"},{"key":"10.1016\/j.pbb.2019.03.006_bb0735","doi-asserted-by":"crossref","first-page":"E339","DOI":"10.9778\/cmajo.20180023","article-title":"The adverse health effects and harms related to marijuana use: an overview review","volume":"6","author":"Memedovich","year":"2018","journal-title":"CMAJ Open"},{"key":"10.1016\/j.pbb.2019.03.006_bb0740","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.janxdis.2010.10.006","article-title":"The prevalence and clinical implications of self-medication among individuals with anxiety disorders","volume":"25","author":"Menary","year":"2011","journal-title":"J. Anxiety Disord."},{"key":"10.1016\/j.pbb.2019.03.006_bb0745","doi-asserted-by":"crossref","first-page":"7109","DOI":"10.1523\/JNEUROSCI.1054-12.2012","article-title":"Bimodal control of fear-coping strategies by CB1 cannabinoid receptors","volume":"32","author":"Metna-Laurent","year":"2012","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2019.03.006_bb0750","doi-asserted-by":"crossref","DOI":"10.1891\/0889-8391.25.1.31","article-title":"Acute effects of marijuana smoking on negative and positive affect","volume":"25","author":"Metrik","year":"2011","journal-title":"J. Cogn. Psychother."},{"key":"10.1016\/j.pbb.2019.03.006_bb0755","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.ejphar.2018.07.039","article-title":"Endocannabinoid system, stress and HPA axis","volume":"834","author":"Micale","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2019.03.006_bb0760","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ntt.2018.06.003","article-title":"Effect of repeated juvenile exposure to \u03949-tetrahydrocannabinol on anxiety-related behavior and social interactions in adolescent rats","volume":"69","author":"Mohammed","year":"2018","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.pbb.2019.03.006_bb0765","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/S0196-9781(00)00324-7","article-title":"Localization of the CB1 cannabinoid receptor in the rat brain. An immunohistochemical study\u2606","volume":"21","author":"Moldrich","year":"2000","journal-title":"Peptides"},{"key":"10.1016\/j.pbb.2019.03.006_bb0770","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(07)61162-3","article-title":"Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review","volume":"370","author":"Moore","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.pbb.2019.03.006_bb0775","first-page":"103","article-title":"Molecular targets of the phytocannabinoids: a complex picture","volume":"103","author":"Morales","year":"2017","journal-title":"Prog. Chem. Org. Nat. Prod."},{"key":"10.1016\/j.pbb.2019.03.006_bb0780","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/7854_2009_16","article-title":"Cannabinoids and anxiety","volume":"2","author":"Moreira","year":"2010","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.pbb.2019.03.006_bb0785","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.beem.2008.09.003","article-title":"Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression","volume":"23","author":"Moreira","year":"2009","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.pbb.2019.03.006_bb0790","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/npp.2015.166","article-title":"Neurobiological interactions between stress and the endocannabinoid system","volume":"41","author":"Morena","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2019.03.006_bb0795","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/npp.2015.166","article-title":"Neurobiological interactions between stress and the endocannabinoid system","volume":"41","author":"Morena","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2019.03.006_bb0800","doi-asserted-by":"crossref","first-page":"74","DOI":"10.2741\/3677","article-title":"Central neural pathways for thermoregulation","volume":"16","author":"Morrison","year":"2011","journal-title":"Front. Biosci. (Landmark Ed.)"},{"key":"10.1016\/j.pbb.2019.03.006_bb0805","article-title":"Cannabis-based medicines for chronic neuropathic pain in adults","volume":"3","author":"M\u00fccke","year":"2018","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.pbb.2019.03.006_bb0810","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1089\/can.2017.0034","article-title":"Chronic adolescent \u03949-tetrahydrocannabinol treatment of male mice leads to long-term cognitive and behavioral dysfunction, which are prevented by concurrent cannabidiol treatment","volume":"2","author":"Murphy","year":"2017","journal-title":"Cannabis Cannabinoid Res."},{"key":"10.1016\/j.pbb.2019.03.006_bb0815","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1021\/cn100005p","article-title":"Cannabinoid conditioned reward and aversion: behavioral and neural processes","volume":"1","author":"Murray","year":"2010","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.pbb.2019.03.006_bb0820","article-title":"Single and combined effects of plant-derived and synthetic cannabinoids on cognition and cannabinoid-associated withdrawal signs in mice","author":"Myers","year":"2018","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pbb.2019.03.006_bb0825","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.tins.2017.02.002","article-title":"The insula: an underestimated brain area in clinical neuroscience, psychiatry, and neurology","volume":"40","author":"Namkung","year":"2017","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.pbb.2019.03.006_bb0830","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00429-010-0268-7","article-title":"The insula and drug addiction: an interoceptive view of pleasure, urges, and decision-making","volume":"214","author":"Naqvi","year":"2010","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.pbb.2019.03.006_bb0835","author":"National Academies of Sciences, Engineering, and Medicine"},{"key":"10.1016\/j.pbb.2019.03.006_bb0840","author":"National Academies of Sciences, Engineering, and Medicine"},{"key":"10.1016\/j.pbb.2019.03.006_bb0845","series-title":"Acute Administration of the CB1 Cannabinoid Receptor Antagonist SR 141716A Induces Anxiety-like Responses in the Rat","volume":"vol. 8","author":"Navarro","year":"1997"},{"key":"10.1016\/j.pbb.2019.03.006_bb0850","series-title":"Does Cannabidiol Protect against Adverse Psychological Effects of THC?","author":"Niesink","year":"2013"},{"key":"10.1016\/j.pbb.2019.03.006_bb0855","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0140-6736(07)60464-4","article-title":"Development of a rational scale to assess the harm of drugs of potential misuse","volume":"369","author":"Nutt","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.pbb.2019.03.006_bb0860","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1038\/nrn3530","article-title":"Effects of Schedule I drug laws on neuroscience research and treatment innovation","volume":"14","author":"Nutt","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.pbb.2019.03.006_bb0865","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1176\/appi.ajp.2017.17040413","article-title":"Cannabis use and risk of prescription opioid use disorder in the United States","volume":"175","author":"Olfson","year":"2018","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pbb.2019.03.006_bb0870","doi-asserted-by":"crossref","DOI":"10.1016\/S0022-3565(25)13195-9","article-title":"Pharmacological characterization of cannabinoids in the elevated plus maze","volume":"253","author":"Onaivi","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2019.03.006_bb0875","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0001640","article-title":"Brain neuronal CB2 cannabinoid receptors in drug abuse and depression: from mice to human subjects","volume":"3","author":"Onaivi","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.pbb.2019.03.006_bb0880","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1177\/0269881111400652","article-title":"CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity","volume":"26","author":"Onaivi","year":"2012","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.pbb.2019.03.006_bb0885","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/npp.2011.34","article-title":"Deletion of CB2 cannabinoid receptor induces schizophrenia-related behaviors in mice","volume":"36","author":"Ortega-Alvaro","year":"2011","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2019.03.006_bb0890","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2006.02.004","article-title":"Deorphanization of a G protein-coupled receptor for oleoylethanolamide and its use in the discovery of small-molecule hypophagic agents","volume":"3","author":"Overton","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.pbb.2019.03.006_bb0895","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neubiorev.2016.12.033","article-title":"The endocannabinoid system as a target for novel anxiolytic drugs","volume":"76","author":"Patel","year":"2017","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.pbb.2019.03.006_bb0900","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.biopsych.2006.03.042","article-title":"An insular view of anxiety","volume":"60","author":"Paulus","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2019.03.006_bb0905","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.neuropharm.2013.07.002","article-title":"Interoception and drug addiction","volume":"76","author":"Paulus","year":"2014","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2019.03.006_bb0910","series-title":"Lysophosphatidylinositol Signalling: New Wine From an Old Bottle","author":"Pi\u00f1eiro","year":"2012"},{"key":"10.1016\/j.pbb.2019.03.006_bb0915","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1124\/jpet.301.3.1020","article-title":"Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor","volume":"301","author":"Porter","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2019.03.006_bb0920","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.jpsychires.2013.12.008","article-title":"Functional connectivity alterations in brain networks relevant to self-awareness in chronic cannabis users","volume":"51","author":"Pujol","year":"2014","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.pbb.2019.03.006_bb0925","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/fcp.12099","article-title":"Central administration of GPR55 receptor agonist and antagonist modulates anxiety-related behaviors in rats","volume":"29","author":"Rahimi","year":"2015","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.pbb.2019.03.006_bb0930","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0031-9384(87)90206-X","article-title":"A reevaluation of the role of the lateral hypothalamus in behavioral temperature regulation","volume":"40","author":"Refinetti","year":"1987","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.pbb.2019.03.006_bb0935","doi-asserted-by":"crossref","first-page":"173","DOI":"10.15171\/ijhpm.2016.114","article-title":"The devil is in the details! On regulating cannabis use in Canada based on public health criteria comment on \u201cLegalizing and regulating marijuana in Canada: review of potential economic, social, and health impacts\u201d","volume":"6","author":"Rehm","year":"2016","journal-title":"Int. J. Health Policy Manag."},{"key":"10.1016\/j.pbb.2019.03.006_bb0940","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.bbr.2006.05.016","article-title":"Effects of cannabidiol and diazepam on behavioral and cardiovascular responses induced by contextual conditioned fear in rats","volume":"172","author":"Resstel","year":"2006","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2019.03.006_bb0945","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1476-5381.2008.00046.x","article-title":"5-HT 1A receptors are involved in the cannabidiol-induced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats","volume":"156","author":"Resstel","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pbb.2019.03.006_bb0950","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.1038\/npp.2012.123","article-title":"Biphasic effects of cannabinoids in anxiety responses: CB1 and GABAB receptors in the balance of GABAergic and glutamatergic neurotransmission","volume":"37","author":"Rey","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2019.03.006_bb0955","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.neuroscience.2017.03.061","article-title":"Anxious behavior induces elevated hippocampal Cb2 receptor gene expression","volume":"352","author":"Robertson","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2019.03.006_bb0960","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000136415","article-title":"Effects of delta9-tetrahydrocannabinol (THC) on several rodent learning paradigms","volume":"10","author":"Robichaud","year":"1973","journal-title":"Pharmacology"},{"key":"10.1016\/j.pbb.2019.03.006_bb0965","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1007\/s00213-017-4626-5","article-title":"Effect of prior foot shock stress and \u03949-tetrahydrocannabinol, cannabidiolic acid, and cannabidiol on anxiety-like responding in the light-dark emergence test in rats","volume":"234","author":"Rock","year":"2017","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2019.03.006_bb0970","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/j.1369-1600.2008.00116.x","article-title":"The endogenous cannabinoid system and drug addiction: 20 years after the discovery of the CB1 receptor","volume":"13","author":"Rodriguez de Fonseca","year":"2008","journal-title":"Addict. Biol."},{"key":"10.1016\/j.pbb.2019.03.006_bb0975","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1111\/add.14238","article-title":"Cannabis and opioid overdoses: time to move on and examine potential mechanisms","volume":"113","author":"Rogeberg","year":"2018","journal-title":"Addiction"},{"key":"10.1016\/j.pbb.2019.03.006_bb0980","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.neuropharm.2007.06.024","article-title":"CB1 receptor stimulation in specific brain areas differently modulate anxiety-related behaviour","volume":"54","author":"Rubino","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2019.03.006_bb0985","series-title":"Beyond Cannabis: Plants and the Endocannabinoid System","author":"Russo","year":"2016"},{"key":"10.1016\/j.pbb.2019.03.006_bb0990","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.neuropharm.2018.11.016","article-title":"Concomitant THC and stress adolescent exposure induces impaired fear extinction and related neurobiological changes in adulthood","volume":"144","author":"Saravia","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2019.03.006_bb0995","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1111\/add.14136","article-title":"Medical marijuana laws and adolescent marijuana use in the United States: a systematic review and meta-analysis","volume":"113","author":"Sarvet","year":"2018","journal-title":"Addiction"},{"key":"10.1016\/j.pbb.2019.03.006_bb1000","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.drugalcdep.2018.01.009","article-title":"Self-medication of mood and anxiety disorders with marijuana: higher in states with medical marijuana laws","volume":"186","author":"Sarvet","year":"2018","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.pbb.2019.03.006_bb1005","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1037\/h0028959","article-title":"Behavioral thermoregulation in rats with anterior hypothalamic lesions","volume":"71","author":"Satinoff","year":"1970","journal-title":"J. Comp. Physiol. Psychol."},{"key":"10.1016\/j.pbb.2019.03.006_bb1010","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0169-328X(98)00277-0","article-title":"Identification and cloning of three novel human G protein-coupled receptor genes GPR52, \u03a8GPR53 and GPR55: GPR55 is extensively expressed in human brain","volume":"64","author":"Sawzdargo","year":"1999","journal-title":"Mol. Brain Res."},{"key":"10.1016\/j.pbb.2019.03.006_bb1015","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1037\/h0046234","article-title":"Cognitive, social, and physiological determinants of emotional state","volume":"69","author":"Schachter","year":"1962","journal-title":"Psychol. Rev."},{"key":"10.1016\/j.pbb.2019.03.006_bb1020","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neuropharm.2007.08.011","article-title":"The endogenous cannabinoid anandamide has effects on motivation and anxiety that are revealed by fatty acid amide hydrolase (FAAH) inhibition","volume":"54","author":"Scherma","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2019.03.006_bb1025","article-title":"Functional effects of synthetic cannabinoids versus \u03949-THC in mice on body temperature, nociceptive threshold, anxiety, cognition, locomotor\/exploratory parameters and depression","author":"Schreiber","year":"2018","journal-title":"Addict. Biol."},{"key":"10.1016\/j.pbb.2019.03.006_bb1030","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/BF00503311","article-title":"Operant thermoregulation of rats with anterior hypothalamic lesions","volume":"318","author":"Schulze","year":"1981","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.pbb.2019.03.006_bb1035","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.ajp.2017.10.003","article-title":"Cannabis induced psychosis and subsequent psychiatric disorders","volume":"30","author":"Shah","year":"2017","journal-title":"Asian J. Psychiatr."},{"key":"10.1016\/j.pbb.2019.03.006_bb1040","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ejphar.2013.09.068","article-title":"Regulation of nausea and vomiting by cannabinoids and the endocannabinoid system","volume":"722","author":"Sharkey","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2019.03.006_bb1045","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13041-017-0318-7","article-title":"The novel cannabinoid receptor GPR55 mediates anxiolytic-like effects in the medial orbital cortex of mice with acute stress","volume":"10","author":"Shi","year":"2017","journal-title":"Mol. Brain"},{"key":"10.1016\/j.pbb.2019.03.006_bb1050","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1124\/jpet.105.089474","article-title":"Agonist-directed trafficking of response by endocannabinoids acting at CB2 receptors","volume":"315","author":"Shoemaker","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2019.03.006_bb1055","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ntt.2016.02.005","article-title":"Sex and age specific effects of delta-9-tetrahydrocannabinol during the periadolescent period in the rat: the unique susceptibility of the prepubescent animal","volume":"58","author":"Silva","year":"2016","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.pbb.2019.03.006_bb1060","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/cam4.1312","article-title":"The current state and future perspectives of cannabinoids in cancer biology","volume":"7","author":"\u015aledzi\u0144ski","year":"2018","journal-title":"Cancer Med."},{"key":"10.1016\/j.pbb.2019.03.006_bb1065","article-title":"Endocannabinoid signaling in psychiatric disorders: a review of positron emission tomography studies","volume":"1","author":"Sloan","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"issue":"720","key":"10.1016\/j.pbb.2019.03.006_bb1070","article-title":"Cannabinoids modulate neuronal activity and cancer by CB1 and CB2 receptor-independent mechanisms","volume":"8","author":"Soderstrom","year":"2017","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.pbb.2019.03.006_bb1075","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1038\/bjp.2008.130","article-title":"The endocannabinoid system in brain reward processes","volume":"154","author":"Solinas","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pbb.2019.03.006_bb1080","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1176\/ajp.2007.164.2.318","article-title":"Increased amygdala and insula activation during emotion processing in anxiety-prone subjects","volume":"164","author":"Stein","year":"2007","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.pbb.2019.03.006_bb1085","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1017\/S0033291706008361","article-title":"Cannabis use disorders in the USA: prevalence, correlates and co-morbidity","volume":"36","author":"Stinson","year":"2006","journal-title":"Psychol. Med."},{"key":"10.1016\/j.pbb.2019.03.006_bb1090","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.euroneuro.2013.12.012","article-title":"Chronic THC during adolescence increases the vulnerability to stress-induced relapse to heroin seeking in adult rats","volume":"24","author":"Stopponi","year":"2014","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pbb.2019.03.006_bb1095","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.pbb.2008.05.010","article-title":"Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures \u2014 a short review","volume":"90","author":"Sv\u00ed\u017eensk\u00e1","year":"2008","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2019.03.006_bb1100","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/15563650.2015.1110590","article-title":"A systematic review of adverse events arising from the use of synthetic cannabinoids and their associated treatment","volume":"54","author":"Tait","year":"2016","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.pbb.2019.03.006_bb1105","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2174\/157488912798842269","article-title":"Cannabinoid-related agents in the treatment of anxiety disorders: current knowledge and future perspectives","volume":"7","author":"Tambaro","year":"2012","journal-title":"Recent Pat. CNS Drug Discov."},{"key":"10.1016\/j.pbb.2019.03.006_bb1110","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3389\/fpsyt.2014.00073","article-title":"The role of cannabinoid transmission in emotional memory formation: implications for addiction and schizophrenia","volume":"5","author":"Tan","year":"2014","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.pbb.2019.03.006_bb1115","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00213-007-0823-y","article-title":"Functional MRI of inhibitory processing in abstinent adolescent marijuana users","volume":"194","author":"Tapert","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2019.03.006_bb1120","series-title":"Anterior Insular Cortex Mediates Bodily Sensibility and Social Anxiety","author":"Terasawa","year":"2013"},{"key":"10.1016\/j.pbb.2019.03.006_bb1125","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/hbm.21458","article-title":"How does interoceptive awareness interact with the subjective experience of emotion? An fMRI Study","volume":"34","author":"Terasawa","year":"2013","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.pbb.2019.03.006_bb1130","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/bph.13333","article-title":"Neural correlates of interactions between cannabidiol and \u03949-tetrahydrocannabinol in mice: implications for medical cannabis","volume":"173","author":"Todd","year":"2016","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.pbb.2019.03.006_bb1135","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/B978-0-12-809666-6.00006-X","article-title":"The role of the endocannabinoid system in addiction","author":"Trigo","year":"2017","journal-title":"Endocannabinoid Syst."},{"key":"10.1016\/j.pbb.2019.03.006_bb1140","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1136\/jech-2016-208145","article-title":"Association of cannabis use with the development of elevated anxiety symptoms in the general population: a meta-analysis","volume":"71","author":"Twomey","year":"2017","journal-title":"J. Epidemiol. Community Health"},{"key":"10.1016\/j.pbb.2019.03.006_bb1145","doi-asserted-by":"crossref","first-page":"703","DOI":"10.3389\/fnins.2018.00703","article-title":"Behavioral and pharmacokinetic profile of indole-derived synthetic cannabinoids JWH-073 and JWH-210 as compared to the phytocannabinoid \u03949-THC in rats","volume":"12","author":"Uttl","year":"2018","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.pbb.2019.03.006_bb1150","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s13311-014-0304-z","article-title":"Neuroprotective properties of cannabigerol in Huntington's disease: studies in R6\/2 mice and 3-nitropropionate-lesioned mice","volume":"12","author":"Valdeolivas","year":"2015","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.pbb.2019.03.006_bb1155","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1017\/S1461145711000526","article-title":"Evidence for involvement of the insula in the psychotropic effects of THC in humans: a double-blind, randomized pharmacological MRI study","volume":"14","author":"van Hell","year":"2011","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pbb.2019.03.006_bb1160","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.pbb.2005.01.029","article-title":"Endocannabinoid system and stress and anxiety responses","volume":"81","author":"Viveros","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2019.03.006_bb1165","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMra1402309","article-title":"Adverse health effects of marijuana use","volume":"370","author":"Volkow","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.pbb.2019.03.006_bb1170","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/npp.2017.222","article-title":"Medical cannabis research: issues and priorities","volume":"43","author":"Ware","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2019.03.006_bb1175","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.jadohealth.2017.02.015","article-title":"The role of public health in combatting synthetic cannabinoid use in adolescents","volume":"60","author":"Warren","year":"2017","journal-title":"J. Adolesc. Health"},{"key":"10.1016\/j.pbb.2019.03.006_bb1180","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2018.1007","article-title":"Association of medical and adult-use marijuana laws with opioid prescribing for medicaid enrollees","author":"Wen","year":"2018","journal-title":"JAMA Intern. Med."},{"key":"10.1016\/j.pbb.2019.03.006_bb1185","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/0306-4522(94)90511-8","article-title":"Cannabinoid receptor binding and messenger RNA expression in human brain: an in vitro receptor autoradiography and in situ hybridization histochemistry study of normal aged and Alzheimer's brains","volume":"63","author":"Westlake","year":"1994","journal-title":"Neuroscience"},{"key":"10.1016\/j.pbb.2019.03.006_bb1190","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1038\/npp.2015.356","article-title":"Double dissociation of monoacylglycerol lipase inhibition and CB1 antagonism in the central amygdala, basolateral amygdala, and the interoceptive insular cortex on the affective properties of acute naloxone-precipitated morphine withdrawal in rats","volume":"41","author":"Wills","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.pbb.2019.03.006_bb1195","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00008877-200509000-00005","article-title":"A role for cannabinoid CB 1 receptors in mood and anxiety disorders","volume":"16","author":"Witkin","year":"2005","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.pbb.2019.03.006_bb1200","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.pnpbp.2017.04.004","article-title":"Prefrontal endocannabinoids, stress controllability and resilience: a hypothesis","volume":"85","author":"Worley","year":"2018","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2019.03.006_bb1205","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1046\/j.1460-9568.1999.00524.x","article-title":"Direct comparison of projections from the central amygdaloid region and nucleus accumbens shell","volume":"11","author":"Zahm","year":"1999","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.pbb.2019.03.006_bb1210","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.neuroimage.2012.05.012","article-title":"Overlapping activity in anterior insula during interoception and emotional experience","volume":"62","author":"Zaki","year":"2012","journal-title":"Neuroimage"},{"key":"10.1016\/j.pbb.2019.03.006_bb1215","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1590\/S1516-44462006000200015","article-title":"History of cannabis as a medicine: a review","volume":"28","author":"Zuardi","year":"2006","journal-title":"Rev. Bras. Psiquiatr."},{"key":"10.1016\/j.pbb.2019.03.006_bb1220","series-title":"Cannabidiol as an Antipsychotic Drug","author":"Zuardi","year":"2006"},{"key":"10.1016\/j.pbb.2019.03.006_bb1225","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.euroneuro.2017.01.011","article-title":"The involvement of cannabinoids and mTOR in the reconsolidation of an emotional memory in the hippocampal\u2013amygdala\u2013insular circuit","volume":"27","author":"Zubedat","year":"2017","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pbb.2019.03.006_bb1230","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1365-2125.2008.03329.x","article-title":"Biomarkers for the effects of cannabis and THC in healthy volunteers","volume":"67","author":"Zuurman","year":"2009","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.pbb.2019.03.006_bb1235","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1016\/j.jpsychires.2007.10.012","article-title":"Prospective associations between cannabis use, abuse, and dependence and panic attacks and disorder","volume":"42","author":"Zvolensky","year":"2008","journal-title":"J. Psychiatr. Res."}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305718303861?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305718303861?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:36:01Z","timestamp":1758774961000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305718303861"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":247,"alternative-id":["S0091305718303861"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2019.03.006","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabinoids, interoception, and anxiety","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2019.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}